Illumina strives to advance awareness of the importance of genetics and health. We recognize that education and clinical research are key to achieving this goal. We are dedicated to providing medical genetics education, supporting independent medical education, and investing in clinical studies. All these endeavors align with our core values and ethical responsibilities.
Illumina is committed to providing health care professionals with accurate, unbiased, and balanced medical genetics information and education. Our education begins with basic genetic concepts and encompasses specific areas of focus including obstetrics, oncology, and rare diseases. This includes support for continuing medical education (CME) activities to help enhance health care providers' knowledge, with the goal of improving patient care.
This information is not a substitute for the exercise of the health care provider’s professional judgment in providing clinical services.
A review of key genetic concepts and principles published in the New England Journal of Medicine.
An update on conceptual and technological advances in genetics and genomics published in the New England Journal of Medicine.
NGS is changing the paradigm in molecular pathology, moving from clinical diagnosis alone to providing evidence supporting treatment recommendations.
In order to translate a patient’s genomic information in a clinically meaningful way, it is essential for oncologists to become acquainted with the capabilities of NGS.
NGS has the potential to change the future of oncology and advance the promise of personalized medicine.
Find visual aids for patient discussions about reproductive genetics concepts such as noninvasive prenatal testing (NIPT).
Designed to help patients explore and learn about prenatal screening and testing options through non-branded educational materials and tools.
Learn about noninvasive prenatal testing, how to order the test for your patients, and insurance coverage.
This course offers an overview of pediatric rare disease, available testing options, and clinical implementation of genomic sequencing. This course may be relevant to laboratory providers, health care providers, health care organizations, and other individuals interested in a review of genomics in the rare disease population.
Understanding the genomics of rare disease can help doctors pinpoint the cause of undiagnosed disorders, helping families avoid long diagnostic odysseys.
Illumina is committed to the advancement of medicine and improvement of patient care by increasing awareness of the utility of genomics in medicine. The current areas of focus for independent medical education include:
All grant proposals are reviewed for compliance with our policies and relevant legal and industry requirements, including guidelines set forth by the Accreditation Council for Continuing Medical Education (ACCME). Requests for an educational grant should be submitted at least 90 days prior to the proposed program date and/or accreditation date. Please submit requests to IMEDgrants@illumina.com.
Clinical research trials are essential to our product development and clinical pipeline. We are committed to patient safety and value the importance of transparency. We are dedicated to sharing clinical trial information and data publicly. For more information about our involvement in clinical trials, visit clinicaltrials.gov.